DJIA 18,074.23 44.02 0.24%
NASDAQ 4,801.34 27.87 0.58%
S&P 500 2,090.08 8.20 0.39%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

90.67 2.49 (2.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $90.67 2.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.86
Previous Close $88.18
Daily Range $88.09 - $91.17
52-Week Range $55.04 - $96.36
Market Cap $13.4B
P/E Ratio -100.20
Dividend (Yield) $0.00 (0.0%)
Volume 223,561
Average Daily Volume 1,223,668
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

4 Biotech Stocks that Doubled in 2014 - Analyst Blog

RBC’s 5 Top Biotech Stocks to Buy for 2015

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog

With Mid-2015 NDA Submission, Sarepta Can Rise

UPDATE: UBS Securities Reiterates On BioMarin Pharmaceutical On Path To Long-Term Upside

Biomarin Pharmaceutical (BMRN) Hits New Lifetime High

FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of

FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of MPS IIIB

5 Biotech Stocks to Buy for 2015

These five biotech stocks may have what it takes to reward investors next year.

See More BMRN News...

BMRN's Top Competitors

BMRN $90.67 (2.82%)
Current stock: BMRN
AMGN $163.07 (1.49%)
Current stock: AMGN
GILD $93.41 (2.32%)
Current stock: GILD
BIIB $339.45 (-0.42%)
Current stock: BIIB